Clinical Trail of the Lay User Study and Method Comparison Study of Human Chorionic Gonadotropin (HCG) Test System
Launched by ANDON HEALTH CO., LTD · Jan 19, 2024
Trial Information
Current as of July 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Method comparison study exclusion criteria
- • Female;
- • 18-55 years of age;
- • Voluntary and sign informed consent form.
- • 2. Lay user study inclusion criteria
- • Female;
- • 18-55 years of age;
- • Voluntary and sign informed consent form;
- • Willingness to perform self-test of investigational device;
- • Have the ability to read English.
- Exclusion Criteria:
- • 1. Method comparison study exclusion criteria
- • Use of hCG-containing fertility medications (e.g., Pregnyl, Profasi, Novarel, Ovidrel);
- • Within 8 weeks of childbirth or abortion;
- • The investigator has reason to believe that it is inappropriate for subjects to participate in the study.
- • 2. Lay user study inclusion criteria
- • Use of hCG-containing fertility medications (e.g., Pregnyl, Profasi, Novarel, Ovidrel);
- • Within 8 weeks of childbirth or abortion;
- • The investigator has reason to believe that it is inappropriate for subjects to participate in the study;
- • Background in a medical or laboratory testing.
About Andon Health Co., Ltd
Andon Health Co., Ltd. is a leading healthcare technology company dedicated to enhancing patient care through innovative medical devices and solutions. With a strong focus on research and development, Andon Health specializes in diagnostic equipment and telemedicine technologies that empower healthcare providers and improve patient outcomes. Committed to advancing medical science, the company actively sponsors clinical trials to validate the efficacy and safety of its products, fostering a collaborative approach to healthcare advancement. Through its rigorous clinical research initiatives, Andon Health aims to contribute to the global healthcare landscape by delivering reliable, cutting-edge solutions that meet the evolving needs of patients and clinicians alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tianjin, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported